[1] Brooks, G.F.,Butel, J.S., Carroll,K.C. and Morse, S.A .(2007). Jawetz , Melnick, and Medical microbiology. 24th ed. McGraw-Hill.p:254-255. New York.
[2] Vuotto, C., Longo, F., Pia,B.M, Donelli, G. and Varaldo, P.E.(2014). Antibiotic Resistance Related to Biofilm Formation in Klebsiella pneumonia. Pathogens: 3: 743-758.
[3] Reid, G., Charbonneau-Smith, R., Lam, D., Kang, Y.S., Lacerte, M., and Hayes, K.C.(1992). Bacterial biofilm formation in the urinary bladder of spinal cord injured patients. Paraplegia, 30(10):711–717.
[4] Yang, D. and Zhang,Z.(2008). Biofilm-forming Klebsiella pneumoniae strains have greater likelihood of producing extended-spectrum beta-lactamases. J. Hosp. Infect. 68: 369–371.
[5] Ryan, K.J.,and Ray, C.G. (2004). Sherris Medical Microbiology(4th ed.). McGraw Hill.p:370. New York.
[6] Brisse,S.,Grimont.F. and Grimont,P.A.D.(2006). The Genus Klebsiella. Prokaryotes, 6:159–196.
[7] Rasmussen, B. A., and Bush,K. (1997). Carbapenem-hydrolyzing B lactamases. Antimicrob. Agents Chemother. 41:223–232.
[8] Grimont,P.A.D. and Grimont, F. (2005). Genus Klebsiella. In: Bergey’s manual of systematic bacteriology . 2nd ed . Vol. (2). Springer. USA.
[9] Tsai, S.S., Huang,J.C., Chen,S.T., Sun,T.H, Wang,C.C., Lin,S.F.,N Hsu,B.R.S, Lin,J.D.,Huang,S.U. and Huang,Y.Y.( 2010). Characteristics of Klebsiella pneumoniae Bacteremia in Community-acquired and Nosocomial Infections in Diabetic Patients. Chang Gung Med J. 33(5): 532-539.
[10] Esposito, E.P, Cervoni, M, Bernardo, M, Crivaro, V, Cuccurullo, S, Imperi, F, and Zarrilli, R.(2019). Molecular Epidemiology and Virulence Profiles of Colistin-Resistant Klebsiella pneumoniae Blood Isolates From the Hospital Agency "Ospedale dei Colli," Naples, Italy. Front Microbiol. 9:1463.
[11] Walter, J., Haller, S., Quinten, C., Kärki ,T., Zacher, B., Eckmanns, T., Abu Sin M, Plachouras, D., Kinross, P., and Suetens, C.(2018) Ecdc Pps Study Group Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey Med J. 2(6): 1022-1027.
[12] Podshun.R. and Ullmann.(1998). Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors. Clin. Microbiol. Rev. 11(4): p. 589–603.
[13] Cortes, G., Borrell, N., de Astorza, B., Gomez, C., Sauleda, J., and Alberti, S. (2002). Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun 70: 2583–2590.
[14] Matatov, R., Goldhar, J., Skutelsky, E., Sechter, I., Perry, R., and Podschun, R.,. (1999) Inability of encapsulated Klebsiella pneumoniae to assemble functional type 1 fimbriae on their surface. FEMS Microbiol Lett. 179: 123–130.
[15] Sahly, H., Navon-Venezia, S.,Roesler, L., Hay, A.,Carmeli, Y., Podschun, R., Hennequin, C.,Forestier, C. and Ofek, I. (2008). Extended-spectrum betalactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniae. Antimicrob Agents Chemother. 52:3029 –3034.
[16] Brisse,S and Grimont,P.A.D.(2006). The Genus Klebsiella. Prokaryotes, 6:159–196.
[17] Straus, D. C. 1987. Production of an extracellular toxic complexby various strains of Klebsiella pneumoniae. Infect. Immun. 55:44–48.
[18] Podschun, R., and Sahly, H. (1991). Hemagglutinins of Klebsiellapneumoniae and K. oxytoca isolated from different sources. Zbl. Hyg. Umweltmed. 191(1):46–52.
[19] Ofek, I., Goldhar,J, Keisari,Y. and Sharon, N. (1995). Nonopsonic phagocytosis of microorganisms. Ann. Rev. Microbiol. 49:239–276.
[20] Przondo-Hessek, A. and Pulverer, G. (1983). Hemagglutininsof Klebsiella pneumoniae and Klebsiella oxytoca. Zbl. Bakteriol. Mikrobiol. Hyg. 255(4):472–478.
[21] Lear, G., and Lewis, G.D. (2012). Microbial Biofilms: Current Research and Applications. Caister Academic Press.p: 96-97.
[22] Yung-Hua, L., Lau P.C.Y., Lee, J.H., Ellen, R.P.and Cvitkovitch, D.G. (2001).Natural genetic transformation of Streptococcus mutans growing in biofilms. J Bacteriol : 183:897–908.
[23] Dunne, W.M.(2002) .Bacterial adhesion: seen any good biofilm lately? Clin. Microbiol. Rev. 15: 155–166.
[24] Toole,G.A. and Kolter,R. (1998). Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30, 295–304.
[25] Davies,D.G. and Geesey, G.G.(1995). Regulation of the alginate biosynthesis gene algC in Pseudomonas aeruginosa during biofilm development in continuous culture. Appl. Environ. Microbiol. 61: 860–867.
[26] Lawrence, J.R.,Korber, D.R., Hoyle, B.D., Costertion, J.W. and Caldwell, D.E.(1991). Optical sectioning of microbial biofilms. J. Bacteriol. 173: 6558–6567.
[27] Costerton, J.W., Lewandowski, Z., Caldwell, D.E.,Korber, D.R, and Lappin-Scott, H.M.(1995). Microbial biofilms. Annu. Rev. Microbiol. 49: 711–745.
[28] Stoodley, P., Sauer, K., Davies, D.G.,and Costerton, J.W.(2002). Biofilms as complex differentiated communities. Annu. Rev. Microbiol. 56: 187–209.
[29] Niveditha, S., Pramodhini, S., Umadevi, S., Kumar, S.and Stephen, S.(2012). The isolation and the biofilm formation of uropathogens in the patients with catheter associated urinary tract infections (UTIs). J. Clin. Diag. Res. 6: 1478–1482.
[30] Singhai, M., Malik, A., Shahid, M., Malik, M.A. and Goyal, R. A.(2012). study on device-related infections with special reference to biofilm production and antibiotic resistance. J. Glob. Infect. Dis. 4: 193–198.
[31] Nicolau-Korres, A.M., Aquije, G.M., Buss, D.S., Ventura, J.A., Fernandes, P.M.and Fernandes, A.A.(2013). Comparison of biofilm and attachment mechanisms of a phytopathological and clinical isolate of Klebsiella pneumoniae subsp. pneumoniae. Sci. World J. 10: 925375.
[32] Donelli, G.and Vuotto, C.(2014). Biofilm-based infections in long-term care facilities. Future Microbiol. 9: 175–188.
[33] Liu, C.and Guo, J.(2020).Characteristics of ventilator-associated pneumonia due to hypervirulent Klebsiella pneumoniae genotype in genetic background for the elderly in two tertiary hospitals in China. Antimicrob Resist Infect Control ;7:95.
[34] Mitharwal, S.M., Yaddanapudi, S., Bhardwaj, N.,Gautam, V., Biswal, M.,and Yaddanapudi, L.(2016). Intensive care unit-acquired infections in a tertiary care hospital: An epidemiologic survey and influence on patient outcomes. Am J Infect Control. 44(7): 113-7.
[35]Venkataraman, R.,Divatia, J.V.,Ramakrishnan, N.,Chawla, R., Amin, P.;Gopal, P.,Chaudhry, D., Zirpe, and K.,Abraham, B.(2018). Multicenter Observational Study to Evaluate Epidemiology and Resistance Patterns of Common Intensive Care Unit-infections. Indian J Crit Care Med. 22(1):20-26.